Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-18

Clinical Trial Update: The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia [NA]

View source ↗

Summary

This document summarizes a terminated clinical trial evaluating how aripiprazole affects reward processing in individuals with schizophrenia. The trial results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Emory University | Conditions: Schizophrenia | NA | Status: TERMINATED | Results posted: 2012-06-18